R. O. Netzer, E. Zollinger, C. Seiler, and A. Cerny, Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995, Heart Br Card Soc, vol.84, pp.25-30, 2000.

J. C. Castillo, M. P. Anguita, A. Ramírez, J. R. Siles, F. Torres et al., Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study, Heart Br Card Soc, vol.83, pp.525-555, 2000.

J. P. Delahaye, P. Poncet, V. Malquarti, J. Beaune, J. P. Garé et al., Cerebrovascular accidents in infective endocarditis: role of anticoagulation, Eur Heart J, vol.11, pp.1074-1082, 1990.

M. Heiro, J. Nikoskelainen, E. Engblom, E. Kotilainen, R. Marttila et al., Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland, Arch Intern Med, vol.160, pp.2781-2788, 2000.

F. Thuny, D. Salvo, G. Disalvo, G. Belliard, O. Avierinos et al., Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study, Circulation, vol.112, pp.69-75, 2005.

B. Hoen, A. F. Selton-suty, C. Béguinot, I. Bouvet, A. Briançon et al., Changing profile of infective endocarditis: results of a 1-year survey in France, JAMA, vol.288, pp.75-81, 2002.

S. A. Dickerman, E. Abrutyn, B. Barsic, E. Bouza, E. Cecchi et al., The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS), Am Heart J, vol.154, pp.1086-94, 2007.

D. Salvo, G. Habib, G. Pergola, V. Avierinos, J. F. Philip et al., Echocardiography predicts embolic events in infective endocarditis, J Am Coll Cardiol, vol.37, pp.1069-76, 2001.

A. J. Sanfilippo, M. H. Picard, J. B. Newell, E. Rosas, R. Davidoff et al., Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications, J Am Coll Cardiol, vol.18, pp.1191-1200, 1991.

R. A. Calderone, M. F. Rotondo, and M. A. Sande, Candida albicans endocarditis: ultrastructural studies of vegetation formation, Infect Immun, vol.20, pp.279-89, 1978.

A. S. Bayer, P. M. Sullam, M. Ramos, C. Li, A. L. Cheung et al., Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains, Infect Immun, vol.63, pp.3634-3675, 1995.

L. I. Kupferwasser, M. R. Yeaman, S. M. Shapiro, C. C. Nast, P. M. Sullam et al., Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects, Circulation, vol.99, pp.2791-2798, 1999.

S. Homma and C. Grahame-clarke, Toward reducing embolic complications from endocarditis, J Am Coll Cardiol, vol.42, pp.781-784, 2003.

L. I. Kupferwasser, M. R. Yeaman, C. C. Nast, D. Kupferwasser, Y. Xiong et al., Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus, J Clin Invest, vol.112, pp.222-255, 2003.

D. P. Nicolau, P. R. Tessier, and C. H. Nightingale, Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis, Int J Antimicrob Agents, vol.11, pp.159-61, 1999.

T. H. Taha, S. S. Durrant, P. K. Mazeika, P. Nihoyannopoulos, and C. M. Oakley, Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis, J Intern Med, vol.231, pp.543-549, 1992.

K. Chan, J. G. Dumesnil, B. Cujec, A. J. Sanfilippo, J. Jue et al., A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis, J Am Coll Cardiol, vol.42, pp.775-80, 2003.

N. S. Anavekar, I. M. Tleyjeh, N. S. Anavekar, Z. Mirzoyev, J. M. Steckelberg et al., Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.44, pp.1180-1186, 2007.

J. Pepin, V. Tremblay, D. Bechard, F. Rodier, C. Walker et al., Chronic antiplatelet therapy and mortality among patients with infective endocarditis, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.15, pp.193-202, 2009.

K. Chan, J. Tam, J. G. Dumesnil, B. Cujec, A. J. Sanfilippo et al., Effect of long-term aspirin use on embolic events in infective endocarditis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.46, pp.37-41, 2008.

D. P. Eisen, G. R. Corey, E. S. Mcbryde, V. G. Fowler, J. M. Miro et al., Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid, J Infect, vol.58, pp.332-340, 2009.

N. S. Anavekar, J. C. Schultz, D. Sa, D. Thomas, J. M. Lahr et al., Modifiers of symptomatic embolic risk in infective endocarditis, Mayo Clin Proc, vol.86, pp.1068-74, 2011.

U. Snygg-martin, R. V. Rasmussen, C. Hassager, N. E. Bruun, R. Andersson et al., The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in left-sided infective endocarditis, Scand J Infect Dis, vol.43, pp.899-904, 2011.

V. L. Serebruany, M. Miller, A. N. Pokov, A. I. Malinin, D. R. Lowry et al., Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study), Am J Cardiol, vol.97, pp.1332-1338, 2006.

K. Schäfer, K. Kaiser, and S. Konstantinides, Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury, Thromb Haemost, vol.93, pp.145-52, 2005.

A. Undas, J. Brozek, and J. Musial, Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease, Clin Lab, vol.48, pp.287-96, 2002.

M. K. Jain and P. M. Ridker, Anti-inflammatory effects of statins: clinical evidence and basic mechanisms, Nat Rev Drug Discov, vol.4, pp.977-87, 2005.

I. M. Tleyjeh, T. Kashour, F. A. Hakim, V. A. Zimmerman, P. J. Erwin et al., Statins for the prevention and treatment of infections: a systematic review and meta-analysis, Arch Intern Med, vol.169, pp.1658-67, 2009.

J. S. Li, D. J. Sexton, M. N. Nettles, R. Fowler, V. G. Ryan et al., Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.30, pp.633-641, 2000.

S. Hatano, Experience from a multicentre stroke register: a preliminary report, Bull World Health Organ, vol.54, pp.541-53, 1976.

D. Firth, Bias reduction of maximum likelihood estimates, Biometrika, vol.82, pp.667-667, 1995.

G. Heinze and M. Schemper, A solution to the problem of separation in logistic regression, Stat Med, vol.21, pp.2409-2428, 2002.

B. F. Farber and A. G. Wolff, The use of nonsteroidal antiinflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers, J Infect Dis, vol.166, pp.861-866, 1992.

R. E. Polonio, L. A. Mermel, G. E. Paquette, and J. F. Sperry, Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin, Antimicrob Agents Chemother, vol.45, pp.3262-3268, 2001.

M. Herrmann, Salicylic acid: an old dog, new tricks, and staphylococcal disease, J Clin Invest, vol.112, pp.149-51, 2003.

C. E. Johnson and H. A. Dewar, Effect of sulphinpyrazone on the development of experimental endocardial vegetations, Cardiovasc Res, vol.16, pp.657-62, 1982.

D. P. Nicolau, M. N. Marangos, C. H. Nightingale, and R. Quintiliani, Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis, Antimicrob Agents Chemother, vol.39, pp.1748-51, 1995.

D. Pruefer, J. Makowski, M. Schnell, U. Buerke, M. Dahm et al., Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin, Circulation, vol.106, pp.2104-2114, 2002.

D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman et al., Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, vol.91, pp.3527-61, 1998.

U. Laufs and J. K. Liao, Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase, J Biol Chem, vol.273, pp.24266-71, 1998.

T. Dutch, . Group, J. Van-gijn, A. Algra, J. Kappelle et al., A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke, N Engl J Med, vol.325, pp.1261-1267, 1991.

J. Weinberger, Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke, Drugs, vol.65, pp.461-71, 2005.